
    
      A double-blind, randomized, placebo-controlled, parallel study comparing the effect of
      tocotrienols vs. placebo will be conducted in subjects with moderately elevated inflammation.
      Subjects will be supplemented with Tocovid Suprabio 200 mg twice daily or placebo for 6
      months. Fasting blood samples will be collected at baseline, 3 months, 6 months. A post-study
      fasting blood sample will be collected at 9 months.
    
  